UC San Diego was the first university in California to connect 40,000 student health records to the electronic health record platform of its top-ranked academic medical center, UC San Diego Health. The experience has created a model for other colleges.
In a randomized, controlled pilot trial published February 13, 2019 in PLOS ONE, UC San Diego School of Medicine researchers found that participants pre-treated with noninvasive vagus nerve stimulation experienced less pain after heat stimulus than mock-treated participants.
University of California San Diego School of Medicine researchers created a new type of brain cancer model for glioblastoma using stem cells, CRISPR and gene sequencing.
Analyzing anonymized patient medical records, UC San Diego researchers discovered that cholesterol-lowering statins reduced risk of severe COVID-19 infection, while lab experiments uncovered a cellular mechanism that helps explain why.
The California Institute for Regenerative Medicine (CIRM) approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.
The California Institute for Regenerative Medicine has approved a trio of awards, totaling approximately $4 million, to UC San Diego School of Medicine researchers to advance studies of new stem cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis.
New UC San Diego Dissemination and Implementation Science Center provides researchers and practitioners with the training, technical assistance, mentoring and resources needed to implement their findings in real-world settings.
Every year, at precisely 9 a.m., medical school graduates nationwide find out where they will spend their residencies. On Friday, the 117 members of the 2019 UC San Diego School of Medicine graduating class will be among them.
A team of researchers in the United States and Japan reports that spinal cord stimulation (SCS) measurably decreased pain and reduced motor symptoms of Parkinson’s disease, both as a singular therapy and as a “salvage therapy” after deep brain stimulation (DBS) therapies were ineffective.
Health Media Contacts
Find the best contact for health-related media inquiries.
